← Pharming Group N.V. PHAR
Market Price
$11.80
Market Cap
$866.23M
P/E Ratio
N/A
Revenue (FY 2025)
↑26.6% YoY
$376.13M
3-Yr CAGR: 22.3%
Net Income
↑96.3% YoY
-$313.00K
Net Margin: -0.1%
Free Cash Flow
↓-70.1% YoY
$1.32M
FCF Yield: 0.15%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity
Efficiency
-0.1%
ROA: -0.1%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (PHAR)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2017 | — | — | — | — | — | — | — | — | — | — |
| FY 2018 | $135.1M | — | $25.8M | $0.9M | — | — | — | $-1.4M | $-3.9M | — |
| FY 2019 | $169.0M | +25.1% | $147.7M | $46.7M | +5,346.8% | — | — | $1.0M | $-1.4M | +65.5% |
| FY 2020 | $185.7M | +9.9% | $165.1M | $38.6M | -17.3% | — | — | $0.6M | $-3.5M | -155.4% |
| FY 2021 | $198.9M | +7.1% | $177.7M | $23.1M | -40.2% | — | — | $0.1M | $-10.7M | -209.7% |
| FY 2022 | $205.6M | +3.4% | $188.1M | $15.0M | -35.1% | — | — | $0.1M | $-1.3M | +87.9% |
| FY 2023 | $245.3M | +19.3% | $220.1M | $-12.0M | -180.1% | — | — | $2.9M | $1.4M | +212.0% |
| FY 2024 | $297.2M | +21.1% | $261.8M | $-8.5M | +29.3% | — | — | $5.2M | $4.4M | +205.0% |
| FY 2025 | $376.1M | +26.6% | $330.6M | $-0.3M | +96.3% | — | — | $2.1M | $1.3M | -70.1% |
Valuation
Market Price
$11.80
Market Cap
$866.23M
Enterprise Value
$836.70M
P/E Ratio
N/A
P/B Ratio
2.99
FCF Yield
0.15%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
87.90%
Operating Margin
6.87%
Net Margin
-0.08%
Return on Equity (ROE)
-0.11%
Return on Assets (ROA)
-0.06%
Asset Turnover
0.75x
Revenue 3-Yr CAGR
22.30%
Financial Health & Liquidity
Current Ratio
2.80
Cash Ratio
1.36
Debt / Equity
0.418
Debt / Assets
0.232
Cash & Equivalents
$145.31M
Total Debt
$115.78M
Book Value / Share
$3.95
Cash Flow Efficiency
Operating Cash Flow
$2.07M
Capital Expenditures (CapEx)
$749.00K
Free Cash Flow
$1.32M
OCF / Revenue
0.55%
FCF / Revenue
0.35%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
N/A
EPS (Basic)
N/A
Dividends / Share
N/A
Book Value / Share
$3.95
EPS YoY Growth
N/A
Balance Sheet (FY 2025)
Total Assets
$499.96M
Total Liabilities
$222.86M
Stockholders' Equity
$277.10M
Current Assets
$299.47M
Current Liabilities
$107.07M